Synapse Open Synapse
Biology

StockWatch: Liquidia Rebounds After Settling Legal Wrangle with United Therapeutics

GEN · · 8 min read

Two weeks after its stock lost more than half its value following a setback in a seven-year legal wrangle, Liquidia shares finally began bouncing back thanks to a settlement with United Therapeutics that drew mixed conclusions from four analysts about which company won out long-term.

Latest from GEN